共 20 条
[1]
Gunther R.W., Vorwerk D., Bohndorf K., Peters I., El-Din A., Messmer B., Iliac and femoral artery stenoses and occlusions: Treatment with intravascular stents, Radiology, 172, pp. 725-730, (1989)
[2]
Long A.L., Page P.E., Raynaud A.C., Beyssen B.M., Fiessinger J.N., Ducimetiere P., Relland J.Y., Gaux J.C., Percutaneous iliac artery stent: Angiographic long-term follow-up, Radiology, 180, pp. 771-778, (1991)
[3]
Strecker E.P., Liermann D., Barth K.H., Wolf H.R., Freudenberg N., Berg G., Westphal M., Tsikuras P., Savin M., Schneider B., Expandable tubular stents for treatment of arterial occlusive disease: Experimental and clinical results, Radiology, 175, pp. 97-102, (1990)
[4]
Trerotola S.O., Lund G.B., Samphilipo M.A., Magee C.A., Newman J.S., Olson J.L., Anderson J.H., Osterman F.A., Palmaz stent in the treatment of central venous stenosis: Safety and efficacy of redilation, Radiology, 190, pp. 379-385, (1994)
[5]
Zollikofer C.L., Antonucci F., Ptyffer M., Redha F., Salomonowitz E., Stuckmann G., Largiader I., Marty A., Arterial stent placement with use of the Wallstent: Midterm results of clinical experience, Radiology, 179, pp. 449-456, (1991)
[6]
Vorwerk D., Gunther R.W., Gehl H.B., Bohndorf K., Colorcoded image-directed Doppler sonography compared with digital subtraction angiography in the follow-up of percutaneous vascular endoprotheses, J Clin Ultrasound, 18, pp. 631-637, (1990)
[7]
Edelman R.R., MR angiography: Present and future, AJR, 161, pp. 1-11, (1993)
[8]
Edelman R., Mattle H.P., Atkinson D., Hoogewoud H.M., MR angiography, AJR, 154, pp. 937-946, (1990)
[9]
Owen R.S., Carpenter J.P., Baum R.A., Perloff L.J., Cope C., Magnetic resonance imaging of angiographically occult runoff vessels in peripheral arterial occlusive disease, N Engl J Med, 326, pp. 1577-1581, (1992)
[10]
Yucel E.K., Kaufman J.A., Geller S.C., Waltman A.C., Atherosclerotic occlusive disease of the lower extremity: Prospective evaluation with two-dimensional time-of-flight MR angiography, Radiology, 187, pp. 637-641, (1993)